Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

58.82

+0.76 (1.31%)

At close: Aug 14, 2026, 4:00 PM EDT

58.94

+0.12 (0.21%)

After-hours: Aug 14, 2026, 7:34 PM EDT

Enliven Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	135.51	98.9	124.12	100.14	75.54	110.02
Short-Term Investments	759.65	363.73	189.32	153.01	-	-
Cash & Short-Term Investments	895.16	462.62	313.44	253.15	75.54	110.02
Cash Growth	82.50%	47.59%	23.82%	235.14%	-31.35%	-15.60%
Prepaid Expenses	12.18	12.26	4.63	2.95	2.22	0.65
Restricted Cash	-	-	0.05	0.05	-	-
Other Current Assets	-	-	-	10	-	-
Total Current Assets	907.34	474.88	318.13	266.15	77.75	110.67
Property, Plant & Equipment	1.64	0.42	0.46	1.06	1.52	0.95
Long-Term Deferred Charges	-	0.22	-	0.56	3.98	1.65
Other Long-Term Assets	1.24	0.66	7.18	4.09	0.05	0.05
Total Assets	910.22	476.17	325.76	271.87	83.3	113.33
Accounts Payable	0.37	2.16	1.34	0.53	3.44	2.52
Accrued Expenses	13.06	13.66	14.37	14.66	4.32	2.84
Current Portion of Leases	0.6	0.4	-	0.34	0.32	0.16
Other Current Liabilities	0.13	0.35	0.2	10.36	1.64	0.23
Total Current Liabilities	14.16	16.57	15.92	25.89	9.72	5.75
Long-Term Leases	0.91	-	-	-	0.28	-
Other Long-Term Liabilities	-	-	-	0.07	0.38	0.71
Total Liabilities	15.07	16.57	15.92	25.96	10.37	6.47
Common Stock	0.07	0.06	0.05	0.04	0	0
Additional Paid-In Capital	1,300	806.37	553.21	400.17	6.04	2.31
Retained Earnings	-403.28	-347.17	-243.47	-154.45	-82.86	-45.2
Comprehensive Income & Other	-1.91	0.33	0.06	0.14	-	-
Total Common Equity	895.15	459.6	309.85	245.91	-76.83	-42.89
Shareholders' Equity	895.15	459.6	309.85	245.91	72.92	106.86
Total Liabilities & Equity	910.22	476.17	325.76	271.87	83.3	113.33
Total Debt	1.51	0.4	-	0.34	0.6	0.16
Net Cash (Debt)	893.65	462.22	313.44	252.81	74.94	109.87
Net Cash Growth	82.41%	47.47%	23.98%	237.37%	-31.79%	-15.66%
Net Cash Per Share	14.10	8.16	6.66	7.11	23.99	14.06
Filing Date Shares Outstanding	73.27	59.8	49	41.35	12.1	11.64
Total Common Shares Outstanding	73.25	59.44	48.94	41.29	12.1	11.64
Working Capital	893.18	458.31	302.21	240.26	68.04	104.92
Book Value Per Share	12.22	7.73	6.33	5.96	-6.35	-3.68
Tangible Book Value	895.15	459.6	309.85	245.91	-76.83	-42.89
Tangible Book Value Per Share	12.22	7.73	6.33	5.96	-6.35	-3.68
Machinery	0.39	0.26	1.38	1.41	1.26	0.65

SEC Filings: 10-K · 10-Q